GOLDMAN SACHS GROUP INC

Holdings History for Transcode Therapeutics, Inc. - Common Stock (RNAZ)

Symbol: RNAZ on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 82 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in Transcode Therapeutics, Inc. Common Stock (RNAZ)

10 Nov 2025 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 82 shares of Transcode Therapeutics, Inc. Common Stock (RNAZ). This represents 0% ownership of the company. In their previous filing dated 14 Aug 2025, GOLDMAN SACHS GROUP INC had reported owning 49,018 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
THE GOLDMAN SACHS GROUP, INC.	0%	-98%	$882	82	-48,936	-100%	$10.76	13G/A	30 Sep 2025	10 Nov 2025, 14:16
THE GOLDMAN SACHS GROUP, INC.	5.9%		$441,162	49,018			$9.00	13G	30 Jun 2025	14 Aug 2025, 14:16

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025			-0%	$0	0	-28,042	-100%	$9.88	Q3 2025
30 Jun 2025		0%	+0%	$218,728	28,042	+28,042	NEW	$7.80	Q2 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.